info@synchemia.com | sales@synchemia.com 
9766925136 
Gliclazide EP Impurity B
_1.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gliclazide is used to treat type 2 diabetes. It's a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.N-Nitroso Gliclazide EP Impurity B is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gliclazide EP Impurity B chemically represented as 2-Nitroso octahydrocyclopenta[c]pyrrole. Synchemia is the leading manufacturing and exporter of N-Nitroso Gliclazide EP Impurity B.We supply N-Nitroso Gliclazide EP Impurity B with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142355 |
| CAS No | NA |
| Mol.F. | C14H18N2O3 |
| Mol.Wt. | 262.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142356 |
| CAS No | NA |
| Mol.F. | C12H14N2O5 |
| Mol.Wt. | 266.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142357 |
| CAS No | NA |
| Mol.F. | C13H15N3O4 |
| Mol.Wt. | 277.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142358 |
| CAS No | NA |
| Mol.F. | C14H16FN3O4 |
| Mol.Wt. | 309.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142359 |
| CAS No | NA |
| Mol.F. | C16H18N2O3 |
| Mol.Wt. | 286.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142360 |
| CAS No | NA |
| Mol.F. | C16H14N2O3 |
| Mol.Wt. | 282.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142361 |
| CAS No | NA |
| Mol.F. | C16H10N2O4 |
| Mol.Wt. | 294.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142362 |
| CAS No | NA |
| Mol.F. | C17H16N2O3 |
| Mol.Wt. | 296.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142363 |
| CAS No | NA |
| Mol.F. | C33H30N4O5 |
| Mol.Wt. | 562.63 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142364 |
| CAS No | NA |
| Mol.F. | C16H14N2O6S |
| Mol.Wt. | 362.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142365 |
| CAS No | NA |
| Mol.F. | C16H14N2O6S |
| Mol.Wt. | 362.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142366 |
| CAS No | NA |
| Mol.F. | C20H15F7N2O4 |
| Mol.Wt. | 480.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142367 |
| CAS No | NA |
| Mol.F. | C23H20F7N5O4 |
| Mol.Wt. | 563.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142368 |
| CAS No | NA |
| Mol.F. | C24H24F7N5O5 |
| Mol.Wt. | 595.47 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142369 |
| CAS No | NA |
| Mol.F. | C4H7ClN4O3 |
| Mol.Wt. | 194.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142370 |
| CAS No | NA |
| Mol.F. | C11H12FN5O3 |
| Mol.Wt. | 281.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
